Aminoxytriphene

Aminoxytriphene
Clinical data
Other namesAmotriphene, Myordil, Win 5494, Rimalcor.
Identifiers
  • 2,3,3-Tris(4-methoxyphenyl)-N,N-dimethylprop-2-en-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC26H29NO3
Molar mass403.522 g·mol−1
3D model (JSmol)
  • CN(C)CC(=C(C1=CC=C(C=C1)OC)C2=CC=C(C=C2)OC)C3=CC=C(C=C3)OC
  • InChI=1S/C26H29NO3/c1-27(2)18-25(19-6-12-22(28-3)13-7-19)26(20-8-14-23(29-4)15-9-20)21-10-16-24(30-5)17-11-21/h6-17H,18H2,1-5H3
  • Key:FRQGJOFRWIILCX-UHFFFAOYSA-N

Amotriphene is a coronary vasodilator that was developed at Sterling Drug in the early 1960s. It has selective binding to alpha-adrenergic receptors.

As a triphenylethylene, it has a structure similar to chlorotrianisene, although it is not thought to function as a non-steroidal synthetic estrogen.

Its pharmacology has been studied.

Synthesis

The literature procedure that was published involved Mannich reaction to desoxyanisoin followed by organometallic addition of anisyl magnesium bromide and dehydration of the resulting alcohol.